Category Archives for "News"

Imaginostics Participates in Start-Up Forum at The Alzheimer’s Drug Discovery Foundation Annual Conference

Imaginostics participated in a start-up forum hosted by The Alzheimer’s Drug Discovery Foundation (ADDF) at their annual conference. CEO Codi Gharagouzloo, PhD, represented Imaginostics, as part of a forum that included other innovative start-ups from around the United States, Canada, and Europe. The annual conference brings together scientists from industry and academia and other professionals committed to drug discovery and related research on Alzheimer’s disease. It is hosted by the Alzheimer’s Drug Discovery Foundation (ADDF) and seeks “to accelerate the development of innovative treatments for Alzheimer’s disease, related dementias and cognitive aging.” Founded in 1998, ADDF focuses on finding treatments for Alzheimer’s and the translation of knowledge on the disease to treatments with particular focus on promising but underfunded areas of research.

Details on the Conference can be found here: https://meetings.alzdiscovery.org/alz-program/

To read about ADDF, please see: https://www.alzdiscovery.org/about-addf

Imaginostics CEO Speaks About Precision Medicine at New Labs + JLABS Series on Existential Medicine

Imagine treatments custom-tailored to the patient, rather than a one-size-fits-all approach. That was a key theme during Monday night’s precision medicine discussion at JLABS in New York City. Imaginostics CEO Dr. Codi Gharaghouzloo was one of four experts who served on the diverse panel. They discussed the current state of precision medicine and how the personalized medicine revolution impacts patient experience and clinical workflow.

The panel discussion was sponsored by New Labs and Johnson & Johnson Innovation, JLABS, along with EY. Additional panelists included:

  • Olivier Elemento, PhD., Director of the Caryl and Israel Englander Institute for Precision Medicine at Weill Cornell Medicine
  • Tammi Jantzen, Co-founder and CFO at Astarte Medical
  • Adlai Goldberg, EY Global Life Sciences Digital, Social and Commercial Innovation Leader.

Event Details: https://www.eventbrite.com/e/existential-medicine-6-personalized-medicine-tickets-81344618945?aff=ey

Imaginostics CEO Speaks About Healthy Aging Technology at Harvard Catalyst Panel

Baby Boomers are leading more active lives than their predecessors, and technology will play an important role in helping these individuals stay healthier longer. Dr. Codi Gharazouloo discussed these themes alongside three other tech innovators during the Harvard Catalyst Panel on healthy aging and technology on Thursday, June 6.

Dr. Ghragouzloo described his invention, the QUTE-CE MRI method, which can possibly diagnose dementia many years before symptoms appear. The breakthrough technology creates “exquisite vascular images that are like a brain map,” he said. Using his method, physicians can look for patterns of vascular abnormalities as biomarkers of early disease.

Additional panelists included:

Read the full article on the Harvard News & Research website: https://hms.harvard.edu/news/technology-healthy-aging

Imaginostics CEO Serves on MIT Enterprise Forum Panel About the Longevity Economy

The massive shift in the demographics of aging is generating unprecedented entrepreneurial opportunities. The world needs scalable, tech-enabled innovations that serve the evolving needs of the rapidly increasing older adult population. Dr. Codi Gharagouzloo discussed these issues this week at the MIT Enterprise Forum panel: Entrepreneurial Opportunities in the Longevity Economy.

This emerging phenomenon – The Longevity Economy – will drive change in every aspect of life, from health care and social services to new hardware and software solutions that allow people to live connected, healthier, fulfilling lives.

Additional panelists included:

Learn more about the MIT Enterprise Forum Panel event here:. https://www.mitforumcambridge.org/event/the-longevity-revolution/

1 2